Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
CASE REPORT
Ahead of Print

MRI-guided stereotactic ablative radiation therapy for liver metastasis from pancreatic cancer


 Department of Radiation Oncology, Tokyo-Edogawa Cancer Centre, Edogawa Hospital, Tokyo, Japan

Correspondence Address:
Yukihiro Hama,
Department of Radiation Oncology, Tokyo-Edogawa Cancer Centre, Edogawa Hospital, 2-24-18 Higashikoiwa, Edogawa, Tokyo, 133-0052
Japan
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcrt.JCRT_1091_20

A 69-year-old man with a history of pancreatic cancer was referred to our hospital for a newly developed solitary liver metastasis. Since the liver metastasis was in contact with the small intestine, it was necessary to perform radiation therapy while simultaneously monitoring the small intestine and liver metastasis, and then, MRI-guided stereotactic ablative radiation therapy (SABR) was performed. There were no radiation-induced adverse events during the treatment and 6 months of follow-up. MRI showed complete regression of the tumor at 6 months after SABR. It seems feasible to perform SABR safely by using MRI-guided radiation therapy system even if liver metastasis developed near the intestinal tract after surgery for pancreatic cancer.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Hama Y
    -  Tate E
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed119    
    PDF Downloaded2    

Recommend this journal